Autologous hematopoietic stem c ...
Limited information is available from developing countries about complications, pattern of infections, and long-term outcome of patients following h ...
Brain positron emission tomogra ...
Covert brain infarction is an emerging concern in patients with β-thalassemia intermedia (TI). We have recently observed a high prevalence (60%) of ...
Single nucleotide polymorphisms ...
Little is known on the impact of polymorphisms in the IL1B gene on outcome in multiple myeloma. In a population-based study of 348 Danish myeloma pa ...
CD14-/CD34+ is the founding pop ...
The origin of endothelial progenitor cells (EPCs) in umbilical cord blood (UCB) is unknown. In this study, we explored the origin of UCB-derived EPC ...
Monitoring MRD with flow cytome ...
This study evaluated the prognostic value of minimal residual disease (MRD) monitoring by four-color flow cytometry (FCM) in patients with acute lym ...
Presenting features and outcome ...
Although the incidence of chronic lymphocytic leukemia (CLL) increases exponentially with age, data on patients 80 years or older at diagnosis are s ...
Possible prediction of underlyi ...
In some instances, because of the lack of mass formation and the absence of prominent lymph node enlargement, diagnosis of lymphoma-associated hemop ...
Genome-wide high density single ...
The current study investigated molecular cytogenetic characteristics of chronic myeloid leukemia (CML) using genome-wide, single nucleotide polymorp ...
Nutritional status independentl ...
Nutritional status is an independent prognostic factor in immunoglobulin light-chain amyloidosis (AL), but its influence on quality of life (QoL) is ...
Nuclei micro-array FISH, a desi ...
Mantle cell lymphoma (MCL) is a rare, specific lymphoma subtype. Though the morphologic and immunophenotypic features of MCL have been well describe ...
Morphology, cytogenetics, and s ...
Isochromosome of the long arm of chromosome 20 with interstitial loss of material [ider(20q)] is a rare cytogenetic abnormality reported in myelodys ...
Efficacy of rituximab in immune ...
We conducted a retrospective survey to assess prescription practice, response rates to rituximab, and the predictive indicators for a response to ri ...
Low incidence of long-term resp ...
Introduction of new chemotherapy regimens over the last decade resulted in 90% survival in patients with Hodgkin lymphoma (HL), which enhances signi ...
Risk factors for infection and ...
This study was performed to evaluate the impact of extended-spectrum β-lactamase (ESBL)-producing bacteremia on outcome in patients with hematologic ...
Risk of hepatitis B virus (HBV) ...
The use of rituximab has been associated with increased risk of hepatitis B virus (HBV) reactivation in patients who are hepatitis B surface antigen ...
Non-gastric marginal zone B cel ...
The optimal treatment strategy and outcome of nongastric marginal zone lymphoma (MZL) remains undefined. The role of rituximab and fludarabine in MZ ...
Allogeneic bone marrow transpla ...
Controversy remains regarding the transplant outcomes of human leukocyte antigen-identical related bone marrow transplantation (BMT) and peripheral ...
Thalidomide, dexamethasone, Dox ...
In newly diagnosed multiple myeloma (MM), three/four-drug combinations as induction therapy seem to be more effective compared with two-drug associa ...
Asian variant of intravascular ...
The Asian variant of intravascular large B cell lymphoma is a special type of intravascular lymphoma with hemophagocytic syndrome and hypercytokinem ...
Age-dependent frequencies of NP ...
Prognosis of AML in elderly patients is poor due to adverse patient characteristics and comorbidities. In addition, disease-associated parameters re ...
Thalidomide, dexamethasone and ...
The treatment of patients with multiple myeloma usually includes many drugs including thalidomide, lenalidomide and bortezomib. Lovastatin and other ...
Platelet activation and functio ...
We monitored platelet activation by means of Pselectin and platelet monocyte aggregates (PMA) and platelet function by whole blood multiple electrod ...
Second line chemotherapy in pat ...
Enteropathy-associated T cell lymphoma (EATL) is a rare disease with a dismal prognosis. Due to the low efficacy of chemotherapy and the poor perfor ...
Effect of thalidomide with melp ...
Thalidomide with melphalan/prednisone (MPT) was defined as standard treatment in elderly patients with multiple myeloma (MM) based on five randomize ...
Similar efficacy of thalidomide ...
Many regimens containing novel drugs have been developed for multiple myeloma (MM). It is not yet clear whether some of the novel agents are better ...